Why the study?
Porto-mesenteric vein thrombosis is a rare, life-threatening complication after laparoscopic sleeve gastrectomy, prompting evaluation of whether to routinely perform thrombophilia workups, extend chemoprophylaxis beyond 3 weeks, and identify risk factors.
Should thrombophilia workup be standard practice and chemoprophylaxis be extended to more than 3 weeks among all bariatric patients to prevent porto-mesenteric vein thrombosis?
Should thrombophilia workup be standard practice and chemoprophylaxis be extended to more than 3 weeks among all bariatric patients to prevent porto-mesenteric vein thrombosis?
This study highlights the need to evaluate extended thromboprophylaxis and routine thrombophilia workup to prevent life-threatening porto-mesenteric vein thrombosis after laparoscopic sleeve gastrectomy.
PMVT after LSG requires clinical vigilance; this Level 5 series leaves open whether thromboprophylaxis protocols should change.
Porto-mesenteric vein thrombosis (PVMT) is a rare but life-threatening complication after laparoscopic sleeve gastrectomy (LSG). Laparoscopic sleeve gastrectomy (LSG) is considered the most common procedure for efficiently realizing weight loss and treating obesity-related co-morbidities. This study aimed to shed light on this relatively rare complication by presenting a series of patients who developed PMVT after LSG in light of the need to change the specific protocol of thromboprophylaxis in bariatric patients. We proposed to answer two questions: whether we should perform a thrombophilia workup as a standard practice and whether we should extend chemoprophylaxis to more than 3 weeks among all bariatric patients. This study also aimed to investigate the possible risk factors and eventually present our updated protocol for PMVT management and prophylaxis.
No takes yet. Share an insight, caveat, or question.
Godoroja-Diarto et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: